Global Bio-Artificial Systems Market Research Report 2016


Report ID : RC-1091 Category : Healthcare Published Date : september 2018
Publisher : S-AND-P Pages : 117 Format : PDF
Production, means the output of Bio-Artificial Systems

Revenue, means the sales value of Bio-Artificial Systems

This report studies Bio-Artificial Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

    Xenios AG (Germany)

    Abbott Diabetes Care, Inc. (USA)

    Vital Therapies, Inc. (USA)

    Baxter International, Inc. (USA)

    Asahi Kasei Medical Co., Ltd. (Japan)

    Medtronic, Inc. (USA)

    HeartWare International, Inc. (USA)

    Fresenius Medical Care AG & Co. KGaA (Germany)

    Thoratec Corp. (USA)

    Toray Medical Co., Ltd. (Japan)

    Nikkiso Co., Ltd. (Japan)

    Nipro Corporation (Japan)

    SynCardia Systems, Inc. (USA)

    Terumo Heart, Inc. (USA)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Bio-Artificial Systems in these regions, from 2011 to 2021 (forecast), like

    North America

    Europe

    China

    Japan

    Southeast Asia

    India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

    Capillary Hollow Fiber Systems

    Direct Perfusion Systems

    Entrapment Based Systems

    Major BAL Devices

    Extracorporeal Liver Assist Device (ELAD)

    Hybrid Artificial Liver Support System

Split by application, this report focuses on consumption, market share and growth rate of Bio-Artificial Systems in each application, can be divided into

    Application 1

    Application 2

    Application 3
Table of Contents
Global Bio-Artificial Systems Market Research Report 2016

1 Bio-Artificial Systems Market Overview

    1.1 Product Overview and Scope of Bio-Artificial Systems

    1.2 Bio-Artificial Systems Segment by Type

        1.2.1 Global Production Market Share of Bio-Artificial Systems by Type in 2015

        1.2.2 Capillary Hollow Fiber Systems

        1.2.3 Direct Perfusion Systems

        1.2.4 Entrapment Based Systems

        1.2.5 Major BAL Devices

        1.2.6 Extracorporeal Liver Assist Device (ELAD)

        1.2.7 Hybrid Artificial Liver Support System

    1.3 Bio-Artificial Systems Segment by Application

        1.3.1 Bio-Artificial Systems Consumption Market Share by Application in 2015

        1.3.2 Application 1

        1.3.3 Application 2

        1.3.4 Application 3

    1.4 Bio-Artificial Systems Market by Region

        1.4.1 North America Status and Prospect (2011-2021)

        1.4.2 Europe Status and Prospect (2011-2021)

        1.4.3 China Status and Prospect (2011-2021)

        1.4.4 Japan Status and Prospect (2011-2021)

        1.4.5 Southeast Asia Status and Prospect (2011-2021)

        1.4.6 India Status and Prospect (2011-2021)

    1.5 Global Market Size (Value) of Bio-Artificial Systems (2011-2021)

2 Global Bio-Artificial Systems Market Competition by Manufacturers

    2.1 Global Bio-Artificial Systems Production and Share by Manufacturers (2015 and 2016)

    2.2 Global Bio-Artificial Systems Revenue and Share by Manufacturers (2015 and 2016)

    2.3 Global Bio-Artificial Systems Average Price by Manufacturers (2015 and 2016)

    2.4 Manufacturers Bio-Artificial Systems Manufacturing Base Distribution, Sales Area and Product Type

    2.5 Bio-Artificial Systems Market Competitive Situation and Trends

        2.5.1 Bio-Artificial Systems Market Concentration Rate

        2.5.2 Bio-Artificial Systems Market Share of Top 3 and Top 5 Manufacturers

        2.5.3 Mergers & Acquisitions, Expansion

3 Global Bio-Artificial Systems Production, Revenue (Value) by Region (2011-2016)

    3.1 Global Bio-Artificial Systems Production and Market Share by Region (2011-2016)

    3.2 Global Bio-Artificial Systems Revenue (Value) and Market Share by Region (2011-2016)

    3.3 Global Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.4 North America Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.5 Europe Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.6 China Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.7 Japan Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.8 Southeast Asia Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

    3.9 India Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Bio-Artificial Systems Supply (Production), Consumption, Export, Import by Regions (2011-2016)

    4.1 Global Bio-Artificial Systems Consumption by Regions (2011-2016)

    4.2 North America Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

    4.3 Europe Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

    4.4 China Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

    4.5 Japan Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

    4.6 Southeast Asia Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

    4.7 India Bio-Artificial Systems Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Bio-Artificial Systems Production, Revenue (Value), Price Trend by Type

    5.1 Global Bio-Artificial Systems Production and Market Share by Type (2011-2016)

    5.2 Global Bio-Artificial Systems Revenue and Market Share by Type (2011-2016)

    5.3 Global Bio-Artificial Systems Price by Type (2011-2016)

    5.4 Global Bio-Artificial Systems Production Growth by Type (2011-2016)

6 Global Bio-Artificial Systems Market Analysis by Application

    6.1 Global Bio-Artificial Systems Consumption and Market Share by Application (2011-2016)

    6.2 Global Bio-Artificial Systems Consumption Growth Rate by Application (2011-2016)

    6.3 Market Drivers and Opportunities

        6.3.1 Potential Applications

        6.3.2 Emerging Markets/Countries

7 Global Bio-Artificial Systems Manufacturers Profiles/Analysis

    7.1 Xenios AG (Germany)

        7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.1.2 Bio-Artificial Systems Product Type, Application and Specification

            7.1.2.1 Type I

            7.1.2.2 Type II

        7.1.3 Xenios AG (Germany) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.1.4 Main Business/Business Overview

    7.2 Abbott Diabetes Care, Inc. (USA)

        7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.2.2 Bio-Artificial Systems Product Type, Application and Specification

            7.2.2.1 Type I

            7.2.2.2 Type II

        7.2.3 Abbott Diabetes Care, Inc. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.2.4 Main Business/Business Overview

    7.3 Vital Therapies, Inc. (USA)

        7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.3.2 Bio-Artificial Systems Product Type, Application and Specification

            7.3.2.1 Type I

            7.3.2.2 Type II

        7.3.3 Vital Therapies, Inc. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.3.4 Main Business/Business Overview

    7.4 Baxter International, Inc. (USA)

        7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.4.2 Bio-Artificial Systems Product Type, Application and Specification

            7.4.2.1 Type I

            7.4.2.2 Type II

        7.4.3 Baxter International, Inc. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.4.4 Main Business/Business Overview

    7.5 Asahi Kasei Medical Co., Ltd. (Japan)

        7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.5.2 Bio-Artificial Systems Product Type, Application and Specification

            7.5.2.1 Type I

            7.5.2.2 Type II

        7.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.5.4 Main Business/Business Overview

    7.6 Medtronic, Inc. (USA)

        7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.6.2 Bio-Artificial Systems Product Type, Application and Specification

            7.6.2.1 Type I

            7.6.2.2 Type II

        7.6.3 Medtronic, Inc. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.6.4 Main Business/Business Overview

    7.7 HeartWare International, Inc. (USA)

        7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.7.2 Bio-Artificial Systems Product Type, Application and Specification

            7.7.2.1 Type I

            7.7.2.2 Type II

        7.7.3 HeartWare International, Inc. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.7.4 Main Business/Business Overview

    7.8 Fresenius Medical Care AG & Co. KGaA (Germany)

        7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.8.2 Bio-Artificial Systems Product Type, Application and Specification

            7.8.2.1 Type I

            7.8.2.2 Type II

        7.8.3 Fresenius Medical Care AG & Co. KGaA (Germany) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.8.4 Main Business/Business Overview

    7.9 Thoratec Corp. (USA)

        7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.9.2 Bio-Artificial Systems Product Type, Application and Specification

            7.9.2.1 Type I

            7.9.2.2 Type II

        7.9.3 Thoratec Corp. (USA) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.9.4 Main Business/Business Overview

    7.10 Toray Medical Co., Ltd. (Japan)

        7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

        7.10.2 Bio-Artificial Systems Product Type, Application and Specification

            7.10.2.1 Type I

            7.10.2.2 Type II

        7.10.3 Toray Medical Co., Ltd. (Japan) Bio-Artificial Systems Production, Revenue, Price and Gross Margin (2015 and 2016)

        7.10.4 Main Business/Business Overview

    7.11 Nikkiso Co., Ltd. (Japan)

    7.12 Nipro Corporation (Japan)

    7.13 SynCardia Systems, Inc. (USA)

    7.14 Terumo Heart, Inc. (USA)

8 Bio-Artificial Systems Manufacturing Cost Analysis

    8.1 Bio-Artificial Systems Key Raw Materials Analysis

       8.1.1 Key Raw Materials

       8.1.2 Price Trend of Key Raw Materials

       8.1.3 Key Suppliers of Raw Materials

       8.1.4 Market Concentration Rate of Raw Materials

    8.2 Proportion of Manufacturing Cost Structure

       8.2.1 Raw Materials

       8.2.2 Labor Cost

       8.2.3 Manufacturing Expenses

    8.3 Manufacturing Process Analysis of Bio-Artificial Systems

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

    9.1 Bio-Artificial Systems Industrial Chain Analysis

    9.2 Upstream Raw Materials Sourcing

    9.3 Raw Materials Sources of Bio-Artificial Systems Major Manufacturers in 2015

    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

    10.1 Marketing Channel

        10.1.1 Direct Marketing

        10.1.2 Indirect Marketing

        10.1.3 Marketing Channel Development Trend

    10.2 Market Positioning

        10.2.1 Pricing Strategy

        10.2.2 Brand Strategy

        10.2.3 Target Client

    10.3 Distributors/Traders List

11 Market Effect Factors Analysis

    11.1 Technology Progress/Risk

        11.1.1 Substitutes Threat

        11.1.2 Technology Progress in Related Industry

    11.2 Consumer Needs/Customer Preference Change

    11.3 Economic/Political Environmental Change

12 Global Bio-Artificial Systems Market Forecast (2016-2021)

    12.1 Global Bio-Artificial Systems Production, Revenue Forecast (2016-2021)

    12.2 Global Bio-Artificial Systems Production, Consumption Forecast by Regions (2016-2021)

    12.3 Global Bio-Artificial Systems Production Forecast by Type (2016-2021)

    12.4 Global Bio-Artificial Systems Consumption Forecast by Application (2016-2021)

    12.5 Bio-Artificial Systems Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

    Author List

    Disclosure Section

    Research Methodology

    Data Source

    China Disclaimer

Sidebar Menu